Teck Announces Pricing of US$550 Million of 10-Year Notes
VANCOUVER, British Columbia, June 23, 2020 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) announced today […]
Ceridian Continues Global Momentum with Launch of Dayforce in Mauritius
EBÈNE, Mauritius, June 23, 2020 (GLOBE NEWSWIRE) — Ceridian (NYSE: CDAY; TSX: CDAY), a global leader in human capital management […]
Editas Medicine Announces Pricing of Offering of Common Stock
CAMBRIDGE, Mass., June 23, 2020 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced […]
TSX News -
IPL Plastics Inc. Announces the Election of Directors
MONTREAL, June 23, 2020 (GLOBE NEWSWIRE) — IPL Plastics Inc. (“IPL Plastics”, “IPLP”, the “Group” or the “Company”) (TSX: IPLP) […]
BRILLIANT ACQUISITION CORPORATION ANNOUNCES PRICING OF $40 MILLION INITIAL PUBLIC OFFERING
New York, NY, June 23, 2020 (GLOBE NEWSWIRE) — Brilliant Acquisition Corporation (NASADAQ: BRLIU) (the “Company”) announced today that its […]
Castor Maritime Inc. Announces Pricing of Upsized $18.0 Million Underwritten Public Offering
LIMASSOL, Cyprus, June 23, 2020 (GLOBE NEWSWIRE) — Castor Maritime Inc. (the “Company”) (NASDAQ: CTRM) announced today the pricing of […]
Palomar Holdings, Inc. Announces Pricing of Public Offering of Common Stock
LA JOLLA, Calif., June 23, 2020 (GLOBE NEWSWIRE) — Palomar Holdings, Inc. (“Palomar” or the “Company”) today announced the pricing […]
Vigil Health Solutions Reports Fiscal 2020 Results
VICTORIA, British Columbia, June 23, 2020 (GLOBE NEWSWIRE) — Vigil Health Solutions Inc. (“Vigil”) announces the results of operations for […]
GW Pharmaceuticals announces that EPIDYOLEX® (cannabidiol) has been reclassified by the UK Home Office as a Schedule 5 drug
GW’s cannabis-based medicine rescheduled following approval by the European Medicines Agency (EMA) and an independent assessment by the Advisory Council […]
MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-001 and MN-002 for the Treatment of Hypertriglyceridemia, Hypercholesterolemia, and Hyperlipoproteinemia in Europe
LA JOLLA, Calif., June 23, 2020 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and […]
